Blockbuster dreams for Pfizer's CDK inhibitor

Nat Biotechnol. 2013 Mar;31(3):187. doi: 10.1038/nbt0313-187a.
No abstract available

Publication types

  • News

MeSH terms

  • Breast Neoplasms / drug therapy
  • Clinical Trials, Phase II as Topic
  • Cyclin-Dependent Kinase 4 / antagonists & inhibitors
  • Cyclin-Dependent Kinase 6 / antagonists & inhibitors
  • Drug Industry*
  • Female
  • Humans
  • Piperazines / pharmacology*
  • Piperazines / therapeutic use*
  • Pyridines / pharmacology*
  • Pyridines / therapeutic use*

Substances

  • Piperazines
  • Pyridines
  • CDK4 protein, human
  • CDK6 protein, human
  • Cyclin-Dependent Kinase 4
  • Cyclin-Dependent Kinase 6
  • palbociclib